Status:

COMPLETED

4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Hepatitis C, Chronic

Eligibility:

All Genders

18-70 years

Phase:

PHASE1

Brief Summary

The main purpose of this clinical trial with BI 207127 is to see the effect of 4 week combination of BI 207127 with Peginterferon alfa (Peg-IFN) and Ribavirin (RBV) on hepatitis C virus (HCV) virus lo...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • HCV genotype 1
  • HCV viral load \>100,000 IU/mL
  • histology or fibroscan to rule out cirrhosis
  • Absence of retinopathy
  • treatment naive patients and treatment experienced patients
  • Age 18 - 70 years
  • Male OR female with documented hysterectomy OR postmenopausal
  • Exclusion criteria:
  • Fertile males not willing to use an adequate form of contraception
  • Pretreatment with any HCV-polymerase inhibitor
  • Any concurrent disease if clinically significant based on the investigator's medical assessment
  • Current alcohol or drug abuse, or history of the same
  • Positive test for HIV or HBs
  • History of malignancy
  • Planned or concurrent usage of any other pharmacological therapy including any antiviral therapy or vaccination
  • Usage of any investigational drug within thirty (30) days prior to enrolment or 5 halflives, whichever is longer
  • Any clinically significant laboratory abnormalities based on the investigator's medical assessment at screening
  • Patients treated with any interferon (approved or investigational) or Peg-IFN and/or Ribavirin within 3 months prior to screening
  • Known hypersensitivity to drugs or excipients; Further exclusion criteria apply

Exclusion

    Key Trial Info

    Start Date :

    May 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    Estimated Enrollment :

    75 Patients enrolled

    Trial Details

    Trial ID

    NCT00905632

    Start Date

    May 1 2009

    Last Update

    April 19 2016

    Active Locations (18)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 5 (18 locations)

    1

    1241.7.3307A CHU de Grenoble

    Grenoble Cédex 9, France

    2

    1241.7.3303A Hôpital Claude Huriez

    Lille, France

    3

    1241.7.3302A Hopital de l'Hotel Dieu

    Lyon, France

    4

    1241.7.3301A Hôpital Saint Eloi

    Montpellier, France